Bruker (BRKR) Stock: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$57.23
1.54 (2.77%)
â˛
5d:
-5.78%
30d:
-10.38%
90d:
+9.07%
WAIT
LOW Confidence
Analysis Updated: Nov 3, 2026 12:00 AM ET
Earnings: Nov 04, 2026
TODAY
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BRKR is fairly priced but lacks strong directional signals. At 3.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BRKR is fairly priced but lacks strong directional signals. At 3.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$76.96
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$47.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $57.23, which is considered fair relative to its 30-day fair value range of $56.24 to $62.49. The stock's valuation (Forward PE: 23.2) is in line with its historical norms (21.2). At these levels, the market is pricing in 3.0% annual earnings growth.
Technical Outlook: Technically, BRKR is in a downtrend. Immediate support is located at $55.15, while resistance sits at $63.39.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $63.83 (+14.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRKR is in a downtrend. Immediate support is located at $55.15, while resistance sits at $63.39.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $63.83 (+14.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$56.24 -
$62.49
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
Protect Your Profits
Holding BRKR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($63.83)
- BULLISH: Expecting earnings turnaround to 3.0% growth with 5.2% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$56.24 -
$62.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$55.15
Resistance Level
$63.39
Current Trend
Downtrend
Technical data as of
Nov 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.17
Wall Street Target
$63.83
(+14.6%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
-81.8%
Profit Margin
-2.0%
Valuation Premium vs History
+3.0% premium
PE vs Historical
23.2 vs 21.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$57.36
(+3%)
2-Year Target
$59.08
(+6%)
3-Year Target
$60.85
(+9%)
3-Yr Target (if PE normalizes)
(PE: 23â21)
PE COMPRESSION
$55.67
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.2, Growth: 13.3%)
$81.10
(+46%)
Base:
(SPY PE: 19.9, Growth: 13.3%)
$69.50
(+25%)
Bear:
(PE: 16.9, Growth: 13.3%)
$59.08
(+6%)
Share & Embed Analysis
Last updated: November 03, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$51 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 45 HOLD |
|
ATEC
Alphatec Holdings Inc |
STRONG BUY
14 analysts |
$14 | 59 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 38 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 27 SELL |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
